Morgan Stanley Children's Hospital of NewYork-Presbyterian is a women's and children's hospital at 3959 Broadway, near West 165th Street, in the Washington Heights neighborhood of Manhattan, New York City. It is a part of NewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.

There are 299 beds in Incarnation Children's Ctr / Columbia Presbyterian Med Ctr.

During the past decade, Incarnation Children's Ctr / Columbia Presbyterian Med Ctr conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 29 clinical trials were completed, i.e. on average, 67.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" #1 sponsor was "Columbia University" with 19 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 17 trials sponsored, "Therapeutic Advances in Childhood Leukemia Consortium" with 10 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Boston Children's Hospital" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 5 trials as a collaborator, "Columbia University" with 5 trials as a collaborator and "Cystic Fibrosis Foundation" with 5 trials as a collaborator. Other collaborators include 156 different institutions and companies that were collaborators in the rest 120 trials.

According to Clinical.Site data, the most researched conditions in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" are "HIV Infections" (15 trials), "Cystic Fibrosis" (5 trials), "Lymphoblastic Leukemia, Acute, Childhood" (4 trials), "Sickle Cell Disease" (4 trials) and "Acute Lymphoblastic Leukemia" (3 trials). Many other conditions were trialed in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" in a lesser frequency.

Most popular intervention types in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" are "Drug" (68 trials), "Device" (10 trials), "Other" (8 trials), "Behavioral" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cytarabine" (7 trials), "Didanosine" (7 trials), "Nevirapine" (6 trials) and "Ritonavir" (6 trials). Other intervention names were less common.

The vast majority of trials in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr" are 100 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, 24 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".